Skip to Main Content
Welcome to theĀ Scientist.comĀ Marketplace

Go to Main Navigation

PICO Predict by Decisive Consulting: An AI-enabled, Human-centred Approach to Preparing for EU-HTA

Decisive Consulting recently launched PICO Predict, a cutting-edge blend of AI technology and human expertise that supports pharmaceutical companies to navigate the European Joint Clinical Assessment (JCA) process being rolled out from 2025.

Importance of PICO Scoping

PICO scoping is central to the new procedure, and with short timelines and minimal manufacturer engagement, it is vital to effectively plan across organisations to ensure governance models, workflows and decision rights are aligned ahead of time.

Reach out to learn more about the potential implications of JCA on your access plans.

PICO Predict Capabilities

PICO Predict accurately replicates the JCA process, to develop core PICOs across all 27 EU member states which is critical for the JCA process and including PICOs, evidence planning, and Systematic Literature Reviews (SLRs), , as can be seen in their latest case study.

Case Study: PICO Predict Replicates EUnetHTA’s PICO Prediction for Pluvicto

A recent case study demonstrates how PICO Predict was used to replicate EUnetHTA’s recent exercise to simulate PICO prediction for radiopharmaceutical prostate cancer medication, pluvicto. The process has proven to accurately predict the consolidated PICOs resulting through JCA scoping. Uploading, screening, and tagging hundreds of documents with the support of a non-generative AI tool, 5 consolidated PICOs were generated based on outputs. As well as accurately predicting PICOs, the tool allows centralisation of data which not only enables the process to be completed in a fraction of the time of the standard JCA process but also allows for replicability and living evidence synthesis. This enables companies to navigate the challenging volumes and timelines of JCA, at the same time as keeping current with landscape changes.

Figure 1 Overview of EUnetHTA21 pluvicto exercise result.Screenshot of data collected, screened and tagged in non-generative AI tool.
Figure 2 Screenshot of data collected, screened and tagged in non-generative AI tool.
Figure 3 Table of consolidated PICOs generated using PICO Predict as a result of case study with comparison to the results of EUnetHTA exercise.

Benefits of PICO Predict

PICO Predict offers accurate and validated predictions for all potential PICO outcomes of the JCA, empowering organisations to anticipate scoping results and prepare accordingly and ahead of time. Our centralised data management and living evidence synthesis ensure replicability and adaptability, allowing systematic literature reviews (SLRs) to be refreshed swiftly in response to changing landscapes. Leveraging cutting-edge technology, our AI-enabled process operates up to 90% faster than traditional manual methods, enabling timely submission and handling of high data volumes. Tailored to individual needs and complexities, PICO Predict is provided as a seamless end-to-end service as well as separate components, ensuring a solution that precisely matches your needs.

Are you JCA ready? Contact Decisive Consulting for more information or book a PICO Predict demo today.